Basic Information
SPIRONOLACTONE
53489-329
Regulatory Information
53489-329
ANDA089424
C73584
January 20, 2023
USA
These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets for oral use Initial U.S. Approval: 1960
HUMAN PRESCRIPTION DRUG LABEL
13
Company Information
146974886
Active Ingredients
ANHYDROUS LACTOSE
Code: 3SY5LH9PMK
Class Code: IACT
CARNAUBA WAX
Code: R12CBM0EIZ
Class Code: IACT
DOCUSATE SODIUM
Code: F05Q2T2JA0
Class Code: IACT
SILICON DIOXIDE
Code: ETJ7Z6XBU4
Class Code: IACT
SODIUM BENZOATE
Code: OJ245FE5EU
Class Code: IACT
HYPROMELLOSE, UNSPECIFIED
Code: 3NXW29V3WO
Class Code: IACT
MAGNESIUM STEARATE
Code: 70097M6I30
Class Code: IACT
MICROCRYSTALLINE CELLULOSE
Code: OP1R32D61U
Class Code: IACT
POLYDEXTROSE
Code: VH2XOU12IE
Class Code: IACT
POVIDONE, UNSPECIFIED
Code: FZ989GH94E
Class Code: IACT
POLYETHYLENE GLYCOL, UNSPECIFIED
Code: 3WJQ0SDW1A
Class Code: IACT
TITANIUM DIOXIDE
Code: 15FIX9V2JP
Class Code: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATO
Code: 5856J3G2A2
Class Code: IACT
TRIACETIN
Code: XHX3C3X673
Class Code: IACT
Active Moieties
SPIRONOLACTONE
Code: 27O7W4T232